Sort
64,565 grants matching “drug discovery”
Factors Influencing Genetic Transcription Initiation And Termination
$1,248,096Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Discovery, characterization and preclinical development of pro-neurogenic drugs
$1,247,957Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2009 · MH
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,247,747Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,247,224Harry Bernard Greenberg · Stanford University · UL1 · FY2010 · RR
Design And Development Of Experimental Therapeutics
$1,247,204Nigel H. Greig · National Institute On Aging · ZIA · FY2017 · AG
Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types
$1,247,028Elizabeth Munding · Cantata Bio Llc · R44 · FY2024 · HG
Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture
$1,246,866Harshini Neelakantan · Ridgeline Therapeutics, Llc · U44 · FY2022 · AG
NCI Program for Natural Products Discovery - Cures
$1,246,805Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The Partnership for Native American Cancer Prevention (2 of 2)
$1,246,698David S Alberts · University Of Arizona · U54 · FY2009 · CA
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$1,246,582Marlene Rabinovitch · Stanford University · R01 · FY2016 · HL
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,246,547Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing
$1,245,214Mark Middleton · Starks Associates, Inc. · N01 · FY2023 · AI
Novel Approaches for Tau PROTAC Drug Discovery
$1,245,086Tauseef R. Butt · Lifesensors, Inc. · R44 · FY2024 · AG
Natural Products Discovery and Characterization Through Network Collaborations
$1,244,726Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
$1,244,641David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2010 · MH
Narcotic Drug and Opioid Peptide Basic Research project
$1,243,955University Of Michigan At Ann Arbor · P01 · FY2004 · DA
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,243,709Robert J Gropler · Washington University · P41 · FY2020 · EB
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
$1,243,570Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Institutional Career Development Core
$1,243,549Inga Peter · Icahn School Of Medicine At Mount Sinai · KL2 · FY2025 · TR
Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease
$1,243,523Robert W. W Williams · University Of Tennessee Health Sci Ctr · R01 · FY2022 · AG
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
$1,243,462Nader Sheibani · University Of Wisconsin-Madison · R24 · FY2013 · EY
Discovery, characterization and preclinical development of pro-neurogenic drugs
$1,243,305Steven L McKnight · Ut Southwestern Medical Center · R01 · FY2011 · MH
Administrative Core
$1,243,218Michael J Bertram · University Of Alabama At Birmingham · P30 · FY2016 · CA
Tissue Engineering Resource Center
$1,243,094David L Kaplan · Tufts University Medford · P41 · FY2011 · EB
Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture
$1,242,959Harshini Neelakantan · Ridgeline Therapeutics, Llc · U44 · FY2023 · AG